B. Kiberd

1.5k total citations
55 papers, 1.1k citations indexed

About

B. Kiberd is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, B. Kiberd has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Transplantation, 18 papers in Surgery and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in B. Kiberd's work include Renal Transplantation Outcomes and Treatments (33 papers), Organ Transplantation Techniques and Outcomes (13 papers) and Organ Donation and Transplantation (10 papers). B. Kiberd is often cited by papers focused on Renal Transplantation Outcomes and Treatments (33 papers), Organ Transplantation Techniques and Outcomes (13 papers) and Organ Donation and Transplantation (10 papers). B. Kiberd collaborates with scholars based in Canada, United States and Australia. B. Kiberd's co-authors include Joseph Lawen, P Belitsky, Kailash Jindal, John S. Gill, Caren Rose, Albert D. Fraser, R. Panek, Kenneth A. West, Catherine M. Clase and Vivian C. McAlister and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American Society of Nephrology and The Journal of Urology.

In The Last Decade

B. Kiberd

54 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Kiberd Canada 19 525 273 247 208 148 55 1.1k
Ricardo Lauzurica Spain 18 390 0.7× 254 0.9× 214 0.9× 196 0.9× 115 0.8× 87 1.1k
C. Galéano Spain 15 292 0.6× 224 0.8× 195 0.8× 276 1.3× 105 0.7× 61 1.1k
Roberto Marcén Spain 16 386 0.7× 269 1.0× 161 0.7× 390 1.9× 88 0.6× 38 1.1k
Alberto Rosati Italy 21 319 0.6× 327 1.2× 92 0.4× 436 2.1× 121 0.8× 73 1.3k
K. Venkateswara Rao United States 20 632 1.2× 364 1.3× 67 0.3× 117 0.6× 169 1.1× 42 1.1k
C. Legendre France 12 463 0.9× 331 1.2× 152 0.6× 221 1.1× 41 0.3× 55 1.2k
Cláudia Rosso Felipe Brazil 22 975 1.9× 397 1.5× 233 0.9× 108 0.5× 266 1.8× 97 1.4k
Anthony Langone United States 17 589 1.1× 327 1.2× 103 0.4× 135 0.6× 138 0.9× 44 1.0k
Jean‐Louis Bosmans Belgium 23 981 1.9× 635 2.3× 128 0.5× 278 1.3× 161 1.1× 61 1.6k
P Vialtel France 12 676 1.3× 350 1.3× 75 0.3× 94 0.5× 126 0.9× 31 921

Countries citing papers authored by B. Kiberd

Since Specialization
Citations

This map shows the geographic impact of B. Kiberd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Kiberd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Kiberd more than expected).

Fields of papers citing papers by B. Kiberd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Kiberd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Kiberd. The network helps show where B. Kiberd may publish in the future.

Co-authorship network of co-authors of B. Kiberd

This figure shows the co-authorship network connecting the top 25 collaborators of B. Kiberd. A scholar is included among the top collaborators of B. Kiberd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Kiberd. B. Kiberd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiberd, B., Karen Doucette, Amanda J. Vinson, & Karthik Tennankore. (2018). Hepatitis C virus–infected kidney waitlist patients: Treat now or treat later?. American Journal of Transplantation. 18(10). 2443–2450. 11 indexed citations
2.
Panek, R., et al.. (2010). Screening for proteinuria in kidney transplant recipients. Nephrology Dialysis Transplantation. 26(4). 1385–1387. 13 indexed citations
3.
Smith, Frank M., R. Panek, & B. Kiberd. (2009). Screening to Prevent Polyoma Virus Nephropathy in Kidney Transplantation: A Cost Analysis. American Journal of Transplantation. 9(9). 2177–2179. 24 indexed citations
4.
Knoll, Greg, Elizabeth A. Cole, John S. Gill, et al.. (2007). The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation study design. Nephrology Dialysis Transplantation. 23(1). 354–358. 40 indexed citations
5.
Kiberd, B., et al.. (2006). Access to the Kidney Transplant Wait List. American Journal of Transplantation. 6(11). 2714–2720. 17 indexed citations
6.
Singh, Dharmendra, et al.. (2006). Polyoma virus-induced hemorrhagic cystitis in renal transplantation patient with polyoma virus nephropathy. Urology. 67(2). 423.e11–423.e12. 11 indexed citations
7.
Barber, Claire, et al.. (2006). BK virus nephropathy in a heart transplant recipient: case report and review of the literature. Transplant Infectious Disease. 8(2). 113–121. 43 indexed citations
8.
Kiberd, B., et al.. (2005). Basiliximab lowers the cyclosporine therapeutic threshold in the early post‐kidney transplant period. Clinical Transplantation. 19(2). 225–229. 4 indexed citations
9.
Kiberd, B., et al.. (2005). Impact of Mycophenolate Mofetil Loading on Drug Exposure in the Early Posttransplant Period. Transplantation Proceedings. 37(5). 2320–2323. 7 indexed citations
10.
11.
Singh, Dharmendra, et al.. (2003). Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients. Transplantation Proceedings. 35(7). 2395–2397. 20 indexed citations
12.
Kiberd, B., et al.. (2001). Impact of acute rejection on long-term graft survival in HLA-identical living-related kidney transplants. Transplantation Proceedings. 33(6). 2982–2983. 3 indexed citations
13.
McAlister, Vivian C., et al.. (2001). Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function. Transplantation Proceedings. 33(1-2). 1038–1039. 31 indexed citations
14.
Barama, Azemi, R. Panek, P Belitsky, et al.. (2000). Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants. Clinical Transplantation. 14(3). 212–217. 34 indexed citations
15.
Mahalati, Kamran, P Belitsky, Kenneth A. West, et al.. (2000). A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels. Transplantation Proceedings. 32(4). 786–787. 8 indexed citations
16.
Conti, D, Thomas A. Gonwa, Philip F. Halloran, et al.. (2000). Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics. Clinical Transplantation. 14(3). 179–188. 61 indexed citations
17.
Kiberd, B., et al.. (1998). Routine treatment of insulin-dependent diabetic patients with ACE inhibitors to prevent renal failure: An economic evaluation. American Journal of Kidney Diseases. 31(1). 49–54. 27 indexed citations
18.
Barama, Azemi, B. Kiberd, P Belitsky, et al.. (1997). Financial impact of cold ischemia time in renal transplantation. Transplantation Proceedings. 29(1-2). 1563–1564. 7 indexed citations
19.
Kiberd, B., et al.. (1996). Metabolic Acidosis in Hemodialysis Patients: A Study of Prevalence and Factors Affecting Intradialytic Bicarbonate Gain. Artificial Organs. 20(9). 976–980. 8 indexed citations
20.
Chagnac, Avry, B. Kiberd, M.C. Fariñas, et al.. (1989). Outcome of the acute glomerular injury in proliferative lupus nephritis.. Journal of Clinical Investigation. 84(3). 922–930. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Lauzurica Breakdown of academic impact, for papers by C. Galéano Breakdown of academic impact, for papers by Roberto Marcén Breakdown of academic impact, for papers by Alberto Rosati Breakdown of academic impact, for papers by K. Venkateswara Rao Breakdown of academic impact, for papers by C. Legendre Breakdown of academic impact, for papers by Cláudia Rosso Felipe Breakdown of academic impact, for papers by Anthony Langone Breakdown of academic impact, for papers by Jean‐Louis Bosmans Breakdown of academic impact, for papers by P Vialtel
Rankless by CCL
2026